Deutsche Bank’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Deutsche Bank’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,061,123	Closed	-$18M	–	6500
2014 Q4	$18M	Buy	1,061,123 +879,399	+484%	+$12.4M	0.01%	1064
2014 Q3	$2.17M	Sell	181,724 -21,957	-11%	-$150K	﹤0.01%	2470
2014 Q2	$1.15M	Sell	203,681 -57,521	-22%	-$265K	﹤0.01%	2844
2014 Q1	$958K	Buy	261,202 +39,268	+18%	+$150K	﹤0.01%	2891
2013 Q4	$744K	Sell	221,934 -429,953	-66%	-$1.78M	﹤0.01%	2832
2013 Q3	$2.75M	Buy	651,887 +472,629	+264%	+$2.24M	﹤0.01%	2257
2013 Q2	$822K	Buy	+179,258	New	+$616K	﹤0.01%	2835

Deutsche Bank's AVNR Position: Q1 2015 in Review

Deutsche Bank sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,061,123 shares — an estimated $18M sold.

Deutsche Bank first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $18M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Deutsche Bank reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 1,061,123 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $18M.
Deutsche Bank first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Deutsche Bank's AVANIR PHARMACEUTICALS, INC CL A position peaked at $18M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.